http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JO-1604-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 |
filingDate | 1989-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1990-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca2c44ffa412f4a774ed9a9d11e730ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82a5becd671e672620c9a683a1f0fdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d9556619b6d135c8098a26ccfd6cb16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74701ae921afb4c90cca99f69a36b162 |
publicationDate | 1990-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JO-1604-B1 |
titleOfInvention | Pyridine derivatives |
abstract | This invention deals with the innovative derivatives of 3.1-kinonic acid from formula (1) that contains half of the pyridil in the fourth position of the dioxan ring and where the groups in the second, fourth and fifth positions are known vacuum chemistry (CES) and where (X) is hydrogen or coccyx or hydroxy and (J) It is phenylin and (n) is 1 or 2 and p1 is the kylin and for the substitutes (c1) and (c2) in the second mode the dioxane loop is a set of values specified later in this text and (c4) is a hydroxy or retarded ghoul or can sulfonamidopo is acceptable Pharmacistically - With pharmaceutically acceptable salts for these substances. This invention also deals with the processes for making and using acidic derivatives as well as pharmaceutical compositions for therapeutic use in one or more diseases such as ischemic heart disease, cerebrovascular disease, asthma and / or inflammatory diseases. |
priorityDate | 1989-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.